Remove 2014 Remove Imaging Remove Nuclear Medicine Remove Radiopharmaceuticals
article thumbnail

Anderson wins SNMMI's Georg Charles de Hevesy Nuclear Pioneer award

AuntMinnie

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer award on Carolyn Anderson, PhD, of the University of Missouri-Columbia (MU). Image courtesy of SNMMI. Additionally, she is an associate editor for the Journal of Nuclear Medicine.

article thumbnail

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer

Imaging Technology

Dr. David Gauden, a co-founder of Blue Earth Diagnostics and with the company since 2014, assumes the role of full-time CEO of Bracco subsidiary Blue Earth Therapeutics. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Carolyn J. Anderson, PhD, Receives SNMMI 2024 Georg Charles de Hevesy Nuclear Pioneer Award

Imaging Technology

Anderson , PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.

article thumbnail

SNMMI Elects Cathy Sue Cutler, PhD, FSNMMI, as President at 2024 Annual Meeting

Imaging Technology

milla1cf Wed, 06/12/2024 - 21:58 June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI , chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, New York, has been named as president for the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

article thumbnail

Cutler named president of SNMMI

AuntMinnie

Cathy Sue Cutler, PhD, has been named president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). As president, I will continue to work to support the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, which will ensure equitable access to care and treatment for patients.”